Nonclinical services for the development of interventional agents for infectious diseases.
Ended Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,905,868
Award facts
- Contract value 100% obligated
- $1,905,868.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12203, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,905,868 |
About this award
This federal contract award, valued at $1,905,868.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Curia Global Inc. (doing business as Amri), a leading global contract development and manufacturing organization (CDMO). The contract is for nonclinical services to support the development of interventional agents for infectious diseases. This is a delivery order contract under the Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The award does not have a set-aside designation. Curia Global has extensive experience supporting various NIH institutes and other federal agencies through prime and subcontract awards, focusing on therapeutic development initiatives in areas such as neurology, infectious diseases, and substance abuse. This contract award aligns with NIAID's mission to conduct and support research to understand, treat, and prevent infectious diseases.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Curia Global Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 19, 2024.
How much is contract 75N93024F00001 worth?
The government has obligated $1,905,868 on 75N93024F00001.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93018D00008, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award